An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease.
about
Defining the earliest pathological changes of Alzheimer's diseaseTransgenic mice overexpressing reticulon 3 develop neuritic abnormalities.Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides.Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disordersAPP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesisBMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injuryCyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosisAltered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's diseaseNovel neuritic clusters with accumulations of amyloid precursor protein and amyloid precursor-like protein 2 immunoreactivity in brain regions damaged by thiamine deficiency.microRNA-21 regulates astrocytic response following spinal cord injuryNeurites containing the neurofilament-triplet proteins are selectively vulnerable to cytoskeletal pathology in Alzheimer's disease and transgenic mouse models.Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy.Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearanceUp-regulation of Synaptotagmin IV within amyloid plaque-associated dystrophic neurons in Tg2576 mouse model of Alzheimer's disease.Polygalae Radix Extract Prevents Axonal Degeneration and Memory Deficits in a Transgenic Mouse Model of Alzheimer's Disease.
P2860
Q28081435-1EF6B35E-B55E-4E23-8D1A-8F17974CECF9Q30479560-1C1D827E-6706-40F2-8749-CBE3111CD320Q30489361-44E7AD42-BCC1-4815-BC74-2C31E643FE96Q32121511-657191E9-12A3-4FAA-8872-67B3D48FB886Q33759956-B8896DC6-CB51-4C57-AF69-51DD5F23E268Q34979181-DE445E28-BB5E-4D41-8A82-844B33A9B306Q35762075-7BF7CD3C-531F-4FD0-8AAF-C8EACF8D0F90Q35773886-B9F02A21-5178-42AD-A88F-2CAEDA1BDD0FQ35782027-E0433C5C-BE1D-4429-85C5-0734933D10F8Q36511567-A225F20F-DA25-46C1-AFA0-8AAF0D497063Q37199238-140E41DF-05FB-4D29-B999-6A0B6130E2C1Q37586721-D5E01FA6-A488-4BF2-8B10-2441D20A4C7CQ38782138-1C0FB704-A9E2-46DD-BDC2-4D6E661EE969Q42922931-1D4999F2-2CC3-43D7-BC9F-44614BE433CEQ44830121-CAB6CF05-8F82-4C79-8C7A-9F0C760F3EC6
P2860
An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
An antibody against phosphoryl ...... axons in Alzheimer's disease.
@en
type
label
An antibody against phosphoryl ...... axons in Alzheimer's disease.
@en
prefLabel
An antibody against phosphoryl ...... axons in Alzheimer's disease.
@en
P2093
P2860
P1476
An antibody against phosphoryl ...... n axons in Alzheimer's disease
@en
P2093
P2860
P304
P407
P577
1993-03-01T00:00:00Z